Ashley Satterfield-Nash1, Ayesha Umrigar2, Tatiana M Lanzieri3. 1. Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee, USA. 2. Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA. 3. National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Abstract
OBJECTIVE: To conduct a scoping review on etiologic investigation of prelingual hearing loss among children <2 years of age in the era of universal newborn hearing screening (UNHS). DATA SOURCES: PubMed, Embase, PsycInfo, CINAHL, and Cochrane Library databases. REVIEW METHODS: We searched for articles published from January 1, 1998, to February 19, 2020. We reviewed studies that (1) included children identified with either congenital or delayed-onset hearing loss before 2 years of age among cohorts who had undergone UNHS and (2) investigated ≥1 etiologies of hearing loss. We defined hearing loss as congenital when confirmed after UNHS failure and as delayed onset when diagnosed after ≥1 assessments with normal hearing. RESULTS: Among 2069 unique citations, 115 studies met criteria for full-text assessment, and 20 met our inclusion criteria. Six studies tested children diagnosed with hearing loss for genetic etiology, 9 for congenital cytomegalovirus (CMV) infection, and 5 for both. Among 1787 children with congenital hearing loss and etiologic investigation, 933 (52.2%) were tested for genetic mutations and 1021 (57.1%) for congenital CMV infection. The proportion of congenital hearing loss cases attributable to genetic etiology ranged between 7.7% and 83.3% and to congenital CMV infection between 0.0% and 32.0%. CONCLUSION: Data are lacking on the identification and etiology of delayed-onset hearing loss in children <2 years of age in the UNHS era. The proportion of congenital hearing loss cases attributable to genetic etiologies and congenital CMV infection appears to vary widely.
OBJECTIVE: To conduct a scoping review on etiologic investigation of prelingual hearing loss among children <2 years of age in the era of universal newborn hearing screening (UNHS). DATA SOURCES: PubMed, Embase, PsycInfo, CINAHL, and Cochrane Library databases. REVIEW METHODS: We searched for articles published from January 1, 1998, to February 19, 2020. We reviewed studies that (1) included children identified with either congenital or delayed-onset hearing loss before 2 years of age among cohorts who had undergone UNHS and (2) investigated ≥1 etiologies of hearing loss. We defined hearing loss as congenital when confirmed after UNHS failure and as delayed onset when diagnosed after ≥1 assessments with normal hearing. RESULTS: Among 2069 unique citations, 115 studies met criteria for full-text assessment, and 20 met our inclusion criteria. Six studies tested children diagnosed with hearing loss for genetic etiology, 9 for congenital cytomegalovirus (CMV) infection, and 5 for both. Among 1787 children with congenital hearing loss and etiologic investigation, 933 (52.2%) were tested for genetic mutations and 1021 (57.1%) for congenital CMV infection. The proportion of congenital hearing loss cases attributable to genetic etiology ranged between 7.7% and 83.3% and to congenital CMV infection between 0.0% and 32.0%. CONCLUSION: Data are lacking on the identification and etiology of delayed-onset hearing loss in children <2 years of age in the UNHS era. The proportion of congenital hearing loss cases attributable to genetic etiologies and congenital CMV infection appears to vary widely.
Authors: K Yeon Choi; Lisa A Schimmenti; Anne M Jurek; Bazak Sharon; Kathy Daly; Cindy Khan; Mark McCann; Mark R Schleiss Journal: Pediatr Infect Dis J Date: 2009-12 Impact factor: 2.129
Authors: Daphne Ari-Even Roth; Daniel Lubin; Jacob Kuint; Michal Teperberg-Oikawa; Ella Mendelson; Tzipora Strauss; Galia Barkai Journal: Arch Dis Child Fetal Neonatal Ed Date: 2017-05-03 Impact factor: 5.747
Authors: Carren J Stika; Laurie S Eisenberg; Karen C Johnson; Shirley C Henning; Bethany G Colson; Dianne Hammes Ganguly; Jean L DesJardin Journal: Early Hum Dev Date: 2014-12-02 Impact factor: 2.079
Authors: Karin M Dent; Aileen Kenneson; Janice C Palumbos; Stacy Maxwell; John Eichwald; Karl White; Rong Mao; James F Bale; John C Carey Journal: Am J Med Genet C Semin Med Genet Date: 2004-02-15 Impact factor: 3.908
Authors: Alexandra Campione; Tatiana M Lanzieri; Emily Ricotta; Scott D Grosse; Sameer S Kadri; Veronique Nussenblatt; D Rebecca Prevots Journal: Curr Med Res Opin Date: 2021-12-06 Impact factor: 2.705